- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04463147
Does the Needle-pilot Device Improve the Success of Vascular Catheterization Compared to the Classical Ultrasound-guided Technique (NEEDLE-VISIO)
November 26, 2025 updated by: Centre Hospitalier Universitaire de Nīmes
Real-time ultrasound guidance for central venous catheter catheterism is recommended in order to reduce complication, in particular for internal jugular site1.
Nevertheless, the usefulness of ultrasound guidance for subclavian approach remains controversial, in particular because needle visualisation is more complex as compared to jugular site2,3.
New magnetic devices (Needle-pilotTM device, Samsung Healthcare) could theoretically allow a better needle visualisation and a better success rate.
The investigators hypothesize that such device could improve the feasibility of subclavian catheterism.
As this device has not been evaluated in patients, the investigators decided to perform a simulation study on a human torso mannequin.
This methodology has been already used by Vogel et al in 20154.
The main objective aims to compare the procedure time between conventional real time ultrasound guidance and guidance with Needle-pilot™ device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nîmes, France
- CHU de Nîmes, Hôpital Universitaire Carémeau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
• all residents and practicioners of intensive care units in the Nîmes University Hospital, France.
Exclusion Criteria:
• unavailability or operator refusal, and more than one year without subclavian central catheterization (for experienced subgroup).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: new residents
new residents in ultrasound-guided central vascular catheterization.
|
The main objective aims to compare the procedure time between conventional real time ultrasound guidance and guidance with Needle-pilotTM device.
|
|
Other: experienced residents or ICU practitioners
experienced residents or ICU practitioners in ultrasound-guided central vascular catheterization.
|
The main objective aims to compare the procedure time between conventional real time ultrasound guidance and guidance with Needle-pilotTM device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First puncture success delay
Time Frame: during the procedure
|
comparison of time (in seconds) between first puncture and successful "blood-aspiration" on a "subclavian venous" torso mannequin.
|
during the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Failure Rate
Time Frame: during the procedure
|
Failure is defined as a puncture time > 300 seconds.
The criterion corresponds to an absolute value: failure or not
|
during the procedure
|
|
Cutaneous wall
Time Frame: during the procedure
|
Counting the number of times each participant will puncture the wall of the mannequin before succeeding in puncturing the vessel with the 2 techniques and comparing this number between groups.
|
during the procedure
|
|
Posterior wall
Time Frame: during the procedure
|
Number of posterior vessel wall penetration
|
during the procedure
|
|
Puncture comfort
Time Frame: immediately after the procedure
|
Operator puncture comfort feeling is assessed from 0 to 10 by each participants for each technique.
|
immediately after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2019
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
February 14, 2020
First Submitted That Met QC Criteria
July 3, 2020
First Posted (Actual)
July 9, 2020
Study Record Updates
Last Update Posted (Estimated)
December 4, 2025
Last Update Submitted That Met QC Criteria
November 26, 2025
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- LOCAL/2019/AC-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Venous Catheters
-
University of Wisconsin, MadisonCompletedCentral Venous CathetersUnited States
-
Ajou University School of MedicineNot yet recruitingCentral Venous Catheters
-
Daping Hospital and the Research Institute of Surgery...Completed
-
Seoul National University HospitalActive, not recruitingCentral Venous CathetersKorea, Republic of
-
Genentech, Inc.CompletedDysfunctional Central Venous Access Catheters
-
Genentech, Inc.CompletedDysfunctional Central Venous Access Catheters
-
ALİEMANNot yet recruitingCentral Venous Catheters/Standards | Ultrasonography/Methods | Ultrasonography/Standards
-
Shandong Branden Med.Device Co.,LtdThird Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingPatients Requiring Peripherally Inserted Central Venous Catheters
-
Hospital Nossa Senhora da ConceicaoNot yet recruitingCatheter Complications | Catheter Related Complication | Central Venous Catheters
-
Zeki Tuncel TekgulCompletedEducation | Simulation Training | Vascular Access Devices | Ultrasonography, Interventional | Central Venous CathetersTurkey
Clinical Trials on Needle-pilotTM device
-
University of Colorado, DenverCook Group IncorporatedCompletedPancreatic CancerUnited States
-
Asan Medical CenterWithdrawnGastrointestinal Subepithelial Tumors
-
Yonsei UniversityCompletedDoctors Attending a Central Line Insertion Training Courses for New Residents of a University Hospital From March 2017 to June 2017 | Physicians Who Had Less Than 10 Ultrasound Guided Internal Jugular Vein Cannulation Participate in This StudyKorea, Republic of
-
Peking Union Medical College HospitalRecruitingAutoimmune PancreatitisChina
-
Intermountain Health Care, Inc.RecruitingSepsis | Emergency Medicine | Device PerformanceUnited States
-
Stanford UniversityCompletedPain | AnxietyUnited States
-
Foundation for Liver ResearchCook Ireland, Ltd.CompletedPancreatic Masses | Lymph NodesFrance, Sweden, Israel, Belgium, Australia, United States, Italy, Japan, Netherlands, Spain
-
Seoul National University HospitalCompletedSagging Eyelid Skin
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
The University of QueenslandBecton, Dickinson and CompanyRecruitingInfection | Blood Culture ContaminationAustralia